TRIP6 functions as a potential oncogene and facilitated proliferation and metastasis of gastric cancer
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - June 10, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - May 27, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - May 21, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - May 20, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Dupilumab side effect in a patient with atopic dermatitis: a case report study
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - May 13, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Systematic review of immunomodulatory therapies for hidradenitis suppurativa
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - May 13, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - May 1, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - April 8, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn & rsquo;s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - January 2, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - December 21, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
The role of microfluidics in protein formulations with pre-programmed functional characteristics
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - December 3, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - November 29, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - November 27, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Structural and functional comparability study of anti-CD20 monoclonal antibody with reference product
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - November 23, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Analysis of drug utilization and health care resource consumption in patients with psoriasis and psoriatic arthritis before and after treatment with biological therapies
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - November 12, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
